• SENSEX 76,496.76
    -258.29 (--0.34%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,936.05 1,745.00(%)
  • Bluestone Jewel
    832.00 872.60(%)
  • Gandhar Oil Ref.
    283.85 245.00(%)
  • Oracle Fin.Serv.
    11,394.75 11,986.90(%)
  • Dr Reddy's Labs
    1,080.05 1,149.00(%)
  • SBI Funds Mgt.
    575.35 582.55(%)
  • Eternal
    291.30 368.40(%)
  • Kalyan Jewellers
    602.00 617.30(%)
  • Tanla Platforms
    625.45 765.75(%)
  • Nippon ETF Liq.
    1,000.01 1,010.50(%)
  • Data Pattern
    4,672.60 2,131.00(%)
  • Adani Green
    1,403.00 767.00(%)
  • Millworks Technologies
    727.95 693.30(%)
  • H P C L
    376.80 316.20(%)
  • HDFC Bank
    746.00 726.75(%)
  • Cupid
    211.00 225.90(%)
  • Wakefit Innovati
    147.95 223.95(%)
  • Dixon Technolog.
    13,971.95 18,471.50(%)
  • Reliance Industries
    1,277.85 1,253.65(%)
  • Uflex
    515.00 609.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gland Pharma Ltd Pharmaceuticals - Indian - Formulations

  • MNC Associate
  • BSE Code : 14546.0
  • ISIN : INE068V01023
2,439.10 -43 (-1.74%)
  • As on 23 Jul 2026 (EOD)

  • Today’s Low

    2,351.10

  • Today’s High

    2,465.00

  • Open

    2,465.00

  • Perv Close

    2,482.40

  • 52W Low

    1,573.60

  • 52W High

    2,573.50

Key Indicators

  • P/E(TTM)

    30.55

  • Mar.Cap (₹Cr.)

    40,235.32

  • Div & Yield %

    0.82

  • Book Value(₹)

    655.32

  • Debt-Equity Ratio

    -1.74

  • AGM Date

    22-Jul-2026

  • EPS

    79.87

  • P/E Ratio

    30.55

Financials Ratios

  • Debt-Equity Ratio

    0.02

  • Mar.Cap (₹Cr.)

    40,235.32

  • RONW (%)

    9.26

  • ROCE (%)

    13.44

Score Board

  • Equity (₹ in Cr.)

    16.50

  • BV (₹)

    655.30

  • Sales( ₹ in Cr.)

    4,552.09

  • NP (in Cr.)

    1,317.59

  • NP Var(%)

    21.0

  • Div%

    2000.0

  • CPS (₹)

    90.60

  • EPS (₹)

    79.90

  • Traded Value (₹ in Lakhs)

    40,254.29

  • 52 Week High

    2,573.50

  • 52 Week Low

    1,573.60

  • Price BSE

    2440.0

  • Price NSE

    2,439.00

  • Market Capital( in Cr.)

    40,254.29

  • P/C Ratio

    26.90

  • P/E Ratio

    30.50

  • Price Vs.BV

    79.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 4,116.15 4,167.43 3,616.53 4,400.71 3,462.88 2,633.24
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4,116.15 4,167.43 3,616.53 4,400.71 3,462.88 2,633.24
Other Income 215.08 166.67 240.46 223.94 134.78 139.17
Stock Adjustments -130.25 -87.43 46.92 -36.69 273.49 6.90
Total Income 4,200.98 4,246.67 3,903.91 4,587.96 3,871.15 2,779.31
EXPENDITURE :            
Raw Materials 1,600.35 1,732.88 1,732.34 2,072.53 1,765.36 1,108.93
Power and Fuel Cost 120.38 117.20 124.84 95.05 74.59 78.50
Employee Cost 439.02 409.95 399.70 338.57 311.36 277.66
Other Manufacturing Expenses 188.89 186.92 153.84 137.19 130.84 102.23
Selling and Administration Expenses 155.54 175.97 189.65 177.43 128.44 98.54
Miscellaneous Expenses 39.10 48.31 100.99 32.61 23.51 18.82
Employee Benefit Expenses 439.02 409.95 399.70 338.57 311.36 277.66
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,543.29 2,671.22 2,701.35 2,853.38 2,434.10 1,684.68
Operating Profit 1,657.70 1,575.44 1,202.55 1,734.58 1,437.04 1,094.63
Interest 22.84 7.84 7.41 5.24 3.41 7.18
Gross Profit 1,634.86 1,567.60 1,195.14 1,729.34 1,433.63 1,087.45
Depreciation 169.27 162.11 146.74 110.30 98.78 94.59
Profit Before Tax 1,465.59 1,405.49 1,048.40 1,619.04 1,334.85 992.86
Current Tax 366.71 337.49 275.38 392.88 337.73 251.83
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 9.12 24.68 -2.80 14.01 0.12 -31.82
Reported Net Profit 1,089.75 1,043.33 775.83 1,212.16 997.01 772.86
Extraordinary Items 0.97 -0.39 -39.55 3.22 0.02 12.99
Adjusted Net Profit 1,088.78 1,043.72 815.38 1,208.94 996.99 759.87
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 7,054.03 6,010.70 5,234.88 4,022.72 3,025.72 2,252.86
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 329.50 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 7,814.28 7,054.03 6,010.70 5,234.88 4,022.72 3,025.72
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,800.00 2,000.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 18.00 20.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 66.14 63.34 47.11 73.78 60.95 49.88
Earnings Per Share(Adj)-Unit Curr 66.14 63.34 47.11 73.78 60.95 -
Book Value 592.08 546.13 482.90 435.68 360.86 235.32
Book Value(Adj)-Unit Curr 592.08 546.13 482.90 435.68 360.86 -

Shareholding Pattern

  • Promoter Group

    51.77%

  • Public Share Holding

    48.23%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 85,393,934 51.77 85,393,934 5
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 85,393,934 51.77 85,393,934 5
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 760 0.00 760 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 102 0.00 102 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 14,417,504 8.74 14,417,504 218
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,106,522 1.28 2,106,522 6
Mutual Funds / UTI 46,573,490 28.23 46,573,490 27
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,538,275 0.93 1,538,275 32
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 64,636,653 39.18 64,636,653 286
2] Non Institution
Bodies Corporate 8,273,866 5.02 2,273,866 689
Clearing Members 38,794 0.02 38,794 33
Directors of their Relatives 77,887 0.05 77,887 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 397,079 0.24 397,079 2,568
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 179,223 0.11 179,223 1,889
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,000,000 0.61 1,000,000 1
Individuals holding nominal share capital up to Rs. 1 lakh 4,772,804 2.89 4,772,804 102,675
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 60,080 0.04 60,080 4
Others 27,026 0.02 27,026 1
Sub Total 14,929,095 9.05 8,929,095 107,975
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 164,959,682 100.00 158,959,682 108,266

Company Background

Gland Pharma LtdPharmaceuticals - Indian - Formulations

  • Gland Pharma Ltd
  • BSE Code : 14546.0
  • ISIN : INE068V01023

  • Incorporation Year

    1978

  • Registered Office

    Sy No 143-148 150&151 Nr Gandi
    X Roads D P Pally Dundigal, Hyderabad,
    Telangana-500043

  • Telephone

    91-40-30510999

  • FAX

    91-40-30510800

  • Chairman

    SRINIVAS SADU

  • Managing Director

  • Company Secretary

  • Auditor

    Deloitte Haskins & Sells

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gland Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Gland Pharma 2,440.25 4,331.22 4,116.15 30.98 15.83
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
J B Chemicals & 2,412.25 3,945.17 3,889.89 57.46 24.24
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77